A.G. Vuillomenet

1.1k total citations
8 papers, 684 citations indexed

About

A.G. Vuillomenet is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, A.G. Vuillomenet has authored 8 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 1 paper in General Health Professions. Recurrent topics in A.G. Vuillomenet's work include Coronary Interventions and Diagnostics (5 papers), Cardiac pacing and defibrillation studies (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). A.G. Vuillomenet is often cited by papers focused on Coronary Interventions and Diagnostics (5 papers), Cardiac pacing and defibrillation studies (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). A.G. Vuillomenet collaborates with scholars based in Switzerland, Netherlands and Greece. A.G. Vuillomenet's co-authors include Hans‐Peter Brunner‐La Rocca, Paul Erné, Hans Rickli, Peter Rickenbacher, Matthias Pfisterer, Urs Jeker, P Hilti, Marc Gutmann, Jürg H. Beer and Thomas Suter and has published in prestigious journals such as The Lancet, JAMA and Journal of the American College of Cardiology.

In The Last Decade

A.G. Vuillomenet

8 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.G. Vuillomenet Switzerland 5 581 261 161 47 46 8 684
Hans H. Osterhues Germany 7 498 0.9× 160 0.6× 113 0.7× 118 2.5× 55 1.2× 9 653
Alain Le Helloco France 7 666 1.1× 130 0.5× 111 0.7× 39 0.8× 68 1.5× 13 715
Antônio Carlos Carvalho Brazil 14 395 0.7× 248 1.0× 107 0.7× 152 3.2× 89 1.9× 63 591
P Hilti Switzerland 4 465 0.8× 86 0.3× 76 0.5× 24 0.5× 45 1.0× 6 516
Valerio Verdiani Italy 11 460 0.8× 69 0.3× 85 0.5× 35 0.7× 54 1.2× 18 536
Natsuhiko Ehara Japan 17 581 1.0× 347 1.3× 411 2.6× 110 2.3× 99 2.2× 57 858
Daisuke Fukamachi Japan 12 291 0.5× 228 0.9× 81 0.5× 147 3.1× 32 0.7× 84 460
J Cassagnes France 14 407 0.7× 339 1.3× 145 0.9× 210 4.5× 82 1.8× 61 684
W Angehrn Switzerland 7 356 0.6× 250 1.0× 79 0.5× 151 3.2× 44 1.0× 22 499
Frédéric Bouisset France 14 405 0.7× 286 1.1× 136 0.8× 165 3.5× 103 2.2× 74 605

Countries citing papers authored by A.G. Vuillomenet

Since Specialization
Citations

This map shows the geographic impact of A.G. Vuillomenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G. Vuillomenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G. Vuillomenet more than expected).

Fields of papers citing papers by A.G. Vuillomenet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.G. Vuillomenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G. Vuillomenet. The network helps show where A.G. Vuillomenet may publish in the future.

Co-authorship network of co-authors of A.G. Vuillomenet

This figure shows the co-authorship network connecting the top 25 collaborators of A.G. Vuillomenet. A scholar is included among the top collaborators of A.G. Vuillomenet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.G. Vuillomenet. A.G. Vuillomenet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Koskinas, Konstantinos C., Masanori Taniwaki, Fabio Rigamonti, et al.. (2016). Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents. The American Journal of Cardiology. 119(4). 501–507. 9 indexed citations
2.
Smits, Pieter C., Georgios J. Vlachojannis, Sjoerd H. Hofma, et al.. (2014). TCT-584 Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: 3 Year Follow-Up from the COMPARE II trial. Journal of the American College of Cardiology. 64(11). B170–B170. 1 indexed citations
3.
Vlachojannis, Georgios J., Pieter C. Smits, Sjoerd H. Hofma, et al.. (2014). TCT-15 Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year follow-up from the COMPARE II trial. Journal of the American College of Cardiology. 64(11). B5–B5. 2 indexed citations
4.
Wijk, Sandra Sanders‐van, Antoinette D. I. van Asselt, Hans Rickli, et al.. (2013). Cost-Effectiveness of N-Terminal Pro-B-Type Natriuretic-Guided Therapy in Elderly Heart Failure Patients. JACC Heart Failure. 1(1). 64–71. 39 indexed citations
5.
Smits, Pieter C., Sjoerd H. Hofma, Mario Togni, et al.. (2013). Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. The Lancet. 381(9867). 651–660. 199 indexed citations
6.
Smits, Peter, Adrianus J. van Boven, Mariano Valdés, et al.. (2012). TCT-573 Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data from COMPARE II study. Journal of the American College of Cardiology. 60(17). B167–B167. 1 indexed citations
7.
Pfisterer, Matthias, Peter Buser, Hans Rickli, et al.. (2009). BNP-Guided vs Symptom-Guided Heart Failure Therapy. JAMA. 301(4). 383–383. 429 indexed citations
8.
Maeder, Micha T., et al.. (2007). Interventional Cardiology in Switzerland during the Year 2005. 10(3). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans H. Osterhues Breakdown of academic impact, for papers by Alain Le Helloco Breakdown of academic impact, for papers by Antônio Carlos Carvalho Breakdown of academic impact, for papers by P Hilti Breakdown of academic impact, for papers by Valerio Verdiani Breakdown of academic impact, for papers by Natsuhiko Ehara Breakdown of academic impact, for papers by Daisuke Fukamachi Breakdown of academic impact, for papers by J Cassagnes Breakdown of academic impact, for papers by W Angehrn Breakdown of academic impact, for papers by Frédéric Bouisset
Rankless by CCL
2026